Portolano Cavallo Studio Legale

Portolano Cavallo provides legal advice to companies operating in complex and evolving sectors: we are leader in the Digital, Media and Technology sectors, in addition to being recognized in the Life Sciences and Fashion/Luxury fields. The firm’s practice areas range from litigation to M&A and venture capital, from emerging companies to the exploitation and protection of intellectual property, from employment to data protection, privacy and cyber-security issues. In all these areaswe are recognized by multiple legal Italian and international rankings and awards. LIFE SCIENCES We are one of the few law firms in Italy able to provide a full-service assistance to clients from the Life Sciences industry. Our experience in the Life Sciences sector encompasses all contractual, contentious, and regulatory aspects of pharmaceuticals, medical devices, health and healthcare services (both digital and traditional), as well as cosmetics and food supplements. The majority of our work is cross-border for domestic and foreign clients (multinationals as well as startups and also technology companies expanding into the Life Sciences sector). We cooperate with universities and polytechnics, healthcare institutions, contract research organizations (CROs), as well as clusters and technology parks, incubators and accelerators. We are one of the members of Biolegis, a pan-European network of independent law firms with in-depth expertise in life sciences.We are members of several Life Sciences-focused associations and initiatives: Antonia Verna has been selected as mentor for the Life Sciences committee of the “Unicredit Startlab” and is member of the Advisory Board of Fondazione Centro San Raffaele; we are members of the Assolombarda Life Sciences Group and an Italian association of pharmaceutical industries (AFI – Associazione Farmaceutici Industria). We have an unmatched competitive advantage compared to the other firms in this industry due to our Digital, Media & Technology leadership in Italy. Digitalization is universally recognized as the new frontier of all Life Sciences: use of big data to develop and deploy pharmaceutical products, exponential growth of “medical devices”, etc. We increasingly often advise on complex legal issues arising through technological developments applied to Life Sciences. We provide legal assistance to clients operating in the Life Sciences industry in the following matters: • during start-up phases • drafting and negotiation of commercial agreements, such as supply, distribution and co-marketing of pharmaceutical products, “toll manufacturing arrangements” drafting and negotiation of joint venture agreements and technology transfers, development, exploitation, valuation, concession and intellectual property acquisition rights agreements, etc. • in various stages of research and product development, from the drafting of contracts relating to clinical trials, including contracts with CROs and investigators, to the resolution of issues that may arise during a trial in the regulatory, compliance and best-practices environments, with regard to the release to the market of medicinal products and medical devices, including advice for the launch of wearables devices and for matters relating to the price and reimbursement of medicines, market access, and the interfacing with public authorities and with other sector operators, as well as for measures restricting the marketing of medicinal products, referral procedures, inspections by regulatory authorities, etc. • in the protection of intellectual and industrial property, both in adversary and out-of-court legal proceedings • in the marketing and advertising of medicines and medical devices or, in general, of products and services in the health and pharmaceutical sector • in matter of antitrust, both in the context of extraordinary transactions and of exploitation of intellectual property rights, with particular focus on all major antitrust and regulatory issues that have become particularly relevant in recent years • in M&A transactions, Private Equity and Venture Capital, both to investors and target businesses • in all matters relating to privacy, cybersecurity and use of big data • in adversary legal proceedingsand for assistance in the performance of internal audit procedures in major Italian and foreign companies OFFICES • In Milan, we are in Piazza Borromeo, 12. • In Rome, we are in Via Rasella, 155. • In New York, we are in Midtown Manhattan at 261 Madison avenue. OUR CLIENTS • more than 50 Fortune Global 500 companies (ranking of the top 500 corporations worldwide as measured by revenue, published annually by Fortune magazine). • one out of two is a US multinational company • eight out of ten are large companies (more than 500 employees) • many companies belonging to healthcare and life sciences industry • a good number of startups and venture capital funds